Admission Date:  [**2136-3-19**]     Discharge Date:  [**2136-3-27**]  Date of Birth:                  Sex:  M  Service:  Biologics  HISTORY OF PRESENT ILLNESS:  Patient is a 42-year-old male with a history of metastatic renal cell carcinoma admitted for cycle one week one of high-dose IL-2.
He underwent a right radical nephrectomy on [**2135-5-25**] revealing adenocarcinoma with predominant clear cell type with anaplastic spindle cell areas firm and grade 4.
Percocet prn.
MS Contin 30 mg p.o.
ALT 26, AST 13, CPK 60, alkaline phosphatase 75, total bilirubin 0.3, albumin 3.4, calcium 8.4, phosphorus 5.1, magnesium 2.0, uric acid 6.
His course was notable for early hypotension initially responding to fluid boluses later requiring dopamine and Neo-Synephrine, vasopressor support.
As per protocol, he was placed on a cardiac monitor, and on [**3-26**] at 7 a.m., he had a run of question of ventricular tachycardia.
Other side-effects during his course included fevers and chills, and an erythematous skin rash.
He also had some nausea and vomiting treated with antiemetic therapy.
His hemoglobin and hematocrit on [**2136-3-21**] were 9.4 and 28.9 respectively, and he was transfused with 2 units of packed red blood cells to help support his blood pressure.
He developed a mild metabolic acidosis with a CO2 of 19 on [**3-24**], treated with bicarb and his maintenance IV fluids.
The side-effects included mild diarrhea treated with antidiarrheals.
Keflex 500 mg p.o.
Ranitidine 150 mg p.o.
Compazine 10 mg p.o.
Ativan 1 mg q.6h.
Benadryl 25-50 mg q.6h.
Tylenol 650 mg p.o.
Motrin 400 mg p.o.
Oxycodone 5-10 mg p.o.
Colace 100 mg p.o.
DIAGNOSIS:  Status post cycle one, week one high-dose IL-2 for metastatic renal cell carcinoma with course complicated by myocarditis.
